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Savior Siblings: The Ethical Debate 
Kristie Trifiolis 
 
 
I. Introduction 
 
Molly Nash was born into the loving arms of parents Lisa and Jack Nash in 1994. When 
she was six years old, it was evident that something was wrong with Molly’s immune system.1 
Her parents received the shocking news that Molly was suffering from Fanconi anemia, a deadly 
genetic disorder characterized by failure of bone marrow production.
2
 Lisa and Jack’s only 
option to save their beloved six year old daughter was to conceive another child who would act 
as a donor to his or her big sister.
3
 
Adam was born on August 29, 2000.
4
 A team of doctors performed a stem cell 
transplantation as soon as he was born and infused these cells into Molly’s circulatory system.5 
After four weeks, Molly showed bone marrow recovery and three years later her immune 
systems were normal.
6
 Adam is a savior sibling conceived in vitro to increase the chances of 
survival or quality of life of his sister.
7
 
What this paper will do is describe in detail the process by which this is procedure is 
performed by discussing the important roles of in vitro fertilization and Preimplantation Genetic 
Diagnosis. The next section of this paper will focus on the ethical considerations surrounding the 
                                                 
1 Amy T. Y. Lai, To Be or Not To Be My Sister's Keeper?, 32 J. LEGAL MED. 261, 261 (2011). 
2 Id. at 262. 
3 Id. 
4 Id. 
5 Id. 
6 Id. 
7 Tim Harrison, Are Savior Siblings a Humane and Proper Use of Reproductive Technology?, 2008, available at 
http://www.nimr.mrc.ac.uk/mill-hill-essays/are-saviour-siblings-a-humane-and-proper-use-of-reproductive-
technology. (last visited April 24, 2013). 
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idea of the creation of a savior sibling. That section will start off by discussing how this idea has 
been mainstreamed through media, followed by the three main arguments against this process: 
(1) children as commodities; (2) the creation of “designer babies”; and (3) the welfare of the 
child. The last part of the ethical section goes through tests that are sometimes used to explore 
the ethical idea of a savior sibling. The following section targets the four different types of 
structures of law that are most commonly used by the United States and many other countries in 
an attempt to regulate the use of Preimplantation Genetic Diagnosis. Following the discussion of 
laws, several U.S. cases will be analyzed that, although not directly on point, help illustrate 
certain points and considerations. The last section of this paper will consist of opinions and 
conclusions based on the following research. 
 
II. The Process of Creating a Savior Sibling 
 
The term savior sibling usually refers to a baby that is created using in vitro fertilization 
(IVF) that was screened during the process using Preimplantation Genetic Diagnosis (PGD) to 
act as a donor match for a child who already exists and is sick in some way.
8
 It is important to 
understand the process of creating a savior sibling before an analysis of the ethical considerations 
can be made. 
In vitro fertilization is fertilization of an egg that happens outside of the body.
9
 A woman 
takes fertility drugs to produce several eggs which are then fertilized by male sperm by being 
                                                 
8 N. R. Ram, Britain’s New Preimplantation Tissue Typing Policy: An Ethical Defence, 32 J. MED. ETHICS 278-282, 
278 (2006). 
9 Id. 
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mixed together in a petri dish and then harvested by a doctor.
10
 Fifteen eggs is the recommended 
number to harvest.
11
 The embryos are then grown for somewhere between two to five days.
12
 At 
that point, the ‘best’ embryos are chosen, based on number of cells, evenness of growth, and 
various other factors, and then implanted into the woman’s uterus.13 IVF has been occurring 
since 1978 and the success rate in 2011 was about one child birth in three attempts.
14
 Studies 
have shown that, although sometimes with multiple attempts, two thirds of couples who try IVF 
eventually have a baby.
15
 
Pre-implantation genetic diagnosis (PGD) is the process of screening IVF embryos to 
prevent inherited disorders.
16
 The PGD procedure usually occurs at about day three.
17
 At this 
point the embryo is around six to ten cells in size.
18
 Acid is used to get inside the embryo, and a 
thin pipette sucks out one cell from the embryo.
19
 This is done by holding the embryo securely 
and having a carefully controlled stream of acid blown through a thin pipette in order to drill a 
hole in the shell of the embryo.
20
 The cell taken is then screened to identify whether the fetus 
                                                 
10 Fertility Factor, Getting Pregnant: In Vitro Fertilization, 2013, available at 
http://www.fertilityfactor.com/infertility_in_vitro_fertilization.html, (last visitied April 24, 2013). 
11 Jenny Hope, Why 15 Harvested Eggs is the Magic Number for an IVF Birth, (2011), available at 
http://www.dailymail.co.uk/health/article-1385709/IVF-15-harvested-eggs-magic-number-successful-live-
birth.html, (last visited April 24, 2013). 
12 Fertility Authority, It Takes Two, 2013, available at http://www.fertilityauthority.com/articles/it-takes-two, (last 
visited April 24, 2013). 
13 BioTech, In Vitro Fertilization Procedure: Applications, Advantages, and Disadvantages, (2012),  available at 
http://www.biotecharticles.com/Applications-Article/In-Vitro-Fertilization-Procedure-Applications-Advantages-
and-Disadvantages-567.html, (last visited April 24, 2013). 
14 RsRevision, Saviour Siblings, 2011, available at 
http://www.rsrevision.com/GCSE/christian_perspectives/genetics/saviour_siblings/introduction.htm (last visited 
April 24, 2013). 
15 Id. 
16 Penn Medicine, Preimplantation Genetic Diagnosis, 2013, available at 
http://www.pennmedicine.org/fertility/patient/clinical-services/pgd-preimplantation-genetic-diagnosis/ (last visited 
April 24, 2013). 
17 See RsRevision, supra note 14. 
18 Id. 
19 Id. 
20 Shiraz Fertility Center, Embryo Transfer and Embryo Implantation, 2009, available at 
http://www.shirazinfertilitycenter.com/en/EmbryoTransfer, (last visited April 24, 2013). 
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might develop a genetic disorder.
21
 PGD can also be used to check if a new baby would be a 
donor match for an existing sick child.
22
 
When the embryo is selected and eventually born, blood from the umbilical cord is 
usually used to treat the sick sibling.
23
 If this does not work, a bone marrow transplant or some 
other tissue or organ transplant may be necessary at some later stage.
24
 
The physician who is along for ride during this process is an important stakeholder for 
several reasons.
25
 First, he or she is the one who starts the entire process of explaining and 
initiating the concept of a savior sibling to the parents.
26
 The physician, in a sense, serves as a 
beacon of hope for these parents trying to save their child.
27
 It is important to remember that the 
physician is doing his or her job by discussing the options to save a child, and, therefore, might 
not realize “the unethical chain of events that can result from a mere suggestion.”28 
The Hippocratic Oath, which physicians tend to recite, states, “I will remember that I do 
not treat a fever chart, a cancerous growth, but a sick human being, whose illness may affect the 
person’s family and economic stability.”29 In an article by Mariana Do Carmo, she explains that 
the phrase “not a cancerous growth, but a sick human being” can be a very powerful phrase in 
justifying the physician’s decision to bring up the idea of a savior sibling to save another child at 
all costs.
30
 This doctor will also most likely serve as the savior child’s physician as well.31 The 
                                                 
21 Genetics Home Reference, Genetic Testing, 2013, available at http://ghr.nlm.nih.gov/handbook/testing?show=all, 
(last visited April 24, 2013). 
22 Katy Duke, Belgian Loophole Allows Swiss Parents a Savior Baby,  368 THE LANCET 355 (2006). 
23 See RsRevision, supra note 14. 
24 Id. 
25 Mariana Do Cormo, Child Autonomy and the Rights to One’s Own Body: PGD and Parental Decision Making, 
2013, available at http://www.thebioethicsproject.org/essays/child-autonomy-and-the-rights-to-ones-own-body-pgd-
and-parental-decision-making/, (last visited May 9, 2013). 
26 Id. 
27 Id. 
28 Id. 
29 Id. 
30 Id. 
31 Id. 
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acts of the physician are not done out of a want to hurt another child, but as a means to save an 
existing child.
32
 While the physician cannot make the choice for the parents, they must explain 
the consequences to the parents of creating a child using PGD.
33
 A physician can, however, step 
in and advocate for the rights of a savior child if that physician feels as though the child is being 
mistreated.
34
 
 
III. The Ethical Considerations 
A. Savior Siblings Go Mainstream 
 The idea of savior sibling went mainstream when a famous novel, later converted into a 
movie, entitled My Sister’s Keeper, allowed the idea of a savior sibling to become a well-known 
topic to the world. This novel is based on a family faced with the idea of creating a savior sibling 
to keep another sibling alive. In 1990, Kate was diagnosed with a rare and aggressive form of 
leukemia.
35
 Kate began chemotherapy almost immediately, and her oncologist suggested she 
might eventually need a bone marrow transplant from a related donor.
36
 The family tested their 
four-year-old son but he was not a match.
37
 The doctor suggested that another unborn sibling 
could be a match and that maybe the family should consider having another child in an attempt 
to save Kate.
38
 
                                                 
32 Id. 
33 Id. 
34 Id. 
35 JODI PICOULT, MY SISTER’S KEEPER, (2003). 
36 Id. 
37 Id. 
38 Id. 
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 The novel is told from the eyes of Sara, the mother, who focuses on the struggles that 
Kate endures.
39
 Anna, the savior sibling, is a perfect genetic match for Kate and over the course 
of a few years, Anna undergoes several procedures including frequent blood withdrawals and 
painful bone marrow extractions in an effort to keep her sister alive.
40
 Sara and her husbands’ 
relationship starts to spin out of control because Sara’s sole focus is on Kate.41 
 The most interesting part of the novel is when Anna, now thirteen, goes to see a lawyer 
and asks him to represent her.
42
 Anna wants to sue her parents for medical emancipation.
43
 She 
did not want to donate a kidney to Kate, who is in the end state of a kidney failure.
44
 When Sara 
was served with the papers for the lawsuit she was enraged at Anna.
45
 The judge in the case 
appointed Anna a guardian ad litem whose sole job was to objectively decide what was in 
Anna’s best interests.46 Anna takes the stand at trial and admits that she filed the lawsuit only 
because Kate asked her to.
47
 My Sister’s Keeper is an emotionally jarring novel that truly speaks 
to the idea of a savior sibling and what impacts it has, as well as touching largely on one of the 
three main arguments that will be discussed below. 
B. Arguments 
The three main arguments that can be found when it comes to the idea of creating a 
savior sibling are that savior siblings would be treated as commodities; the second is a slippery 
slope argument basically suggesting that this type of practice will eventually lead to the creation 
                                                 
39 Id. 
40 Id. 
41 Id. 
42 Id. 
43 Id. 
44 Id. 
45 Id. 
46 Id. 
47 Id. 
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of so-called “designer babies”; and third is a child welfare argument that debates whether a 
savior sibling will be physically, emotionally, or physiologically harmed. 
 
 i. Children as Commodities 
 
One of the most common objections to this procedure lies in the idea that it is wrong to 
bring children into existence “conditionally.”48 This stems from Immanuel Kant’s famous dictum 
“Never use people as a means but always treat them as an end.”49 For example, in medical 
environments, anyone who receives a blood transfusion has used the blood donor as a means to 
their own ends.
50
 
In the view of some, creating a savior sibling is merely conceiving a child to be used as 
an instrument and an object in curing another child.
51
 However, from a broader perspective, 
parents have children for all different sorts of instrumental reasons.
52
 For example, benefits to the 
couple’s marriage, continuity of the family name, economic and psychological benefits to the 
parents, and providing a playmate for an already existing child.
53
 In an article written by B.M. 
Knoppers, she states that most parents have a broad range of reasons and expectations when they 
decide to have children, which, she explains, instrumentalizes them to a degree.
54
 This leads 
some authors to write that as long as the tissue donation would be ethical if performed on an 
existing child, bringing a child into the world to serve as a tissue donor is ethical if the child is 
                                                 
48 Whitney Fasbender, The Savior Child: Having a Child  to Save a Sibling, Is This Right?, 3 J. OF UNDERGRADUATE 
NURSING WRITING 1 (2009). 
49 Id. 
50 Id. 
51 B.M. Knoppers, Preimplantation Genetic Diagnosis: An Overview of Socio-Ethical and Legal Considerations: 
Annual Review of Genomics and Human genetics, 201-221, 212 (2006). 
52 See Fasbender, supra note 48, at 21. 
53 Id. 
54 See Knoppers, supra note 51, at 202. 
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also valued for him or herself.
55
 As long as the parents intend to rear and love the donor child, 
this practice is acceptable.
56
 Supporters of this practice argue that since these parents are making 
the focused effort to try and save their child, it suggests that they are caring and loving parents 
and makes it unlikely that they would treat a new born as a child that was only used to save 
another child.
57
 
 
 ii. Creating “Designer Babies” 
 
The next argument regarding savior siblings is that permitting the deliberate creation of 
savior siblings would be to step onto a slippery slope towards allowing “designer babies”.58 The 
idea is that this technique is a first step towards allowing parents to use embryo testing to choose 
specific characteristics of their baby such as eye or hair color.
59
 This is a fairly simple argument 
that exists out of fear of overuse of technology. 
In an article written by Allison Ford, she explains that although PGD may seem like a 
“miracle”, it may have real-world implications.60 She questions what would stop a couple from 
discarding an embryo based on sex if it is legal to discard an embryo based on faulty genes.
61
 
Approximately forty-two percent of fertility clinics that offer the process of PGD do it for the 
purpose of allowing couples to choose the sex of their child.
62
 These clinics market the idea of 
                                                 
55 Id. 
56 S.M. Wolf, Using Preimplantation Genetic Diagnosis to Create a Stem Cell Donor: Issues, Guidelines, and 
Limits, J. OF LAW MED. AND ETHICS 327-339, 330 (2003). 
57 K. Devolder, Preimplantation HLA typing: Having Children to Save Our Loved Ones, 31 J. MED. ETHICS 582-
586, 584 (2005). 
58 See Fasbender, supra note 48. 
59 Id. 
60 Allison Ford, Designer Babies: Good Idea or Slippery Slope?, 2013, available at 
http://www.divinecaroline.com/life-etc/designer-babies-good-idea-or-slippery-slope, (last visited May 8, 2013). 
61 Id. 
62 Id. 
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sex-selective PGD as a method of balancing a family by allowing families with either several 
sons or several daughters to have a child of the opposite sex.
63
 However, some couples purely 
have a sex preference regardless of the sex of other children.
64
 
As will be discussed in detail in the law section below, the United States has no laws 
against couples choosing the sex of their children, while other countries have deemed the process 
illegal.
65
 Ford enunciates the fact that if scientists are able to isolate genes that are responsible 
for eye color, hair color, or intelligence, then, arbitrarily, couples will be able to create their own 
“prefect child”.66 There is also a fear that these types of techniques would eventually breed out 
certain characteristics that are deemed as generally unwanted.
67
 In a study conducted by New 
York University, respondents expressed their willingness to screen their embryos for height, 
athletic prowess, and intelligence.
68
 
 The last point Ford makes is that, although for most scientists the goals for PGD are to 
prevent disease as opposed to creating the perfect child, “our abilities have outpaced our 
understanding of what is ethical.”69 She questions whether this type of technology would get to a 
point where it is no longer good enough to have a healthy child, but to have a “perfect child.”70 
 
 iii. The Welfare of the Child 
 
The “welfare of the child” argument is the argument that is heavily touched on in My 
Sister’s Keeper. The premise of the child welfare argument is that savior siblings will have 
                                                 
63 Id. 
64 Id. 
65 Id. 
66 Id. 
67 Id. 
68 Id. 
69 Id. 
70 Id. 
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inferior lives to those children who are not born to save another.
71
 Medically, it has been 
suggested that embryo biopsy for PGD does not seem to produce adverse physical effects in the 
short term, but it is too early to exclude the possibility of later effects.
72
 Other factors include 
whether the donations are successful, whether more are required, and whether the sick child is 
cured or dies.
73
 Not only might the new baby know he or she is a savior sibling, but knowing that 
they were an unsuccessful savior sibling could be even worse. 
Proponents of PGD concede that if the child finds out that he or she was wanted not for 
himself or herself, but rather for the ulterior purpose of assisting a sibling to live, this may cause 
psychological harm. However, it is also argued that it is just as likely that that child will feel 
pride and contentment in the knowledge that he or she is responsible for saving the life of a 
sibling. When it comes to psychological harm, there are two theories. First, that the future child 
may suffer harm if he or she finds out that they were not wanted for themselves, but as a means 
to save the life of a sibling.
74
 Second, that a child conceived for this reason is likely to enjoy a 
less close and loving relationship with its parents who are less likely to value and nurture the 
child given they had the child primarily to save the life of a sibling.
75
 Therefore, opponents of 
this practice suggest that no matter how the parents choose to love and care for the new baby, it 
still does not change the fact that this child will most likely be aware that they were born for the 
sole reason of saving their sibling.
76
 
When the donor child eventually can fully understand his or her role in these types of 
events, it is argued that the child may agree with the decision the parents have made and the 
                                                 
71 See Fasbender, supra note 48. 
72 See Duke, supra note 22. 
73 See Knoppers, supra note 51. 
74 Id. 
75 Id. 
76 Id. 
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impact that this child has had on the life of his or her sibling.
77
 However, if the child finds out 
that he or she was unable or is still unable to act as a tissue donor for the sibling, they are much 
more likely to be psychologically damaged.
78
 
The related philosophical argument that ties in here rests upon the presumption that the 
alternative for a savior sibling is not another life in which he or she was conceived in another 
way, but non-existence.
79
 Therefore, the argument is based on the proposition that those who 
object to the creation of a savior sibling must therefore believe that a sibling would have been 
better off were it never to have existed.
80
  
The welfare of the child argument also incorporates the extent of which this new child 
can be expected to be a life long donor subject to repeated tests and procedures.
81
 Along with this 
are the risks associated with the procedures and the extent of which the body is invaded.
82
 
According to an article written by K. Devolder, the ethical standard that should be employed in 
these types of situations is what would be acceptable if the donor child already existed.
83
 The 
harvesting of umbilical cord blood is widely accepted already since it entails no physical 
intrusion and no harm to the embryo.
84
 Bone marrow transplants from young children to their 
siblings have also become widely accepted.
85
 However, harvesting vital organs from children is 
not acceptable in light of the risks involved for the donor child.
86
 
                                                 
77 Id. 
78 Id. 
79 Id. 
80 Id. 
81 See Wolf, supra note 56. 
82 Id. 
83 See Devolder, supra note 57. 
84 Id. 
85 Id. 
86 Id. 
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Bone marrow donation, for instance, involves a number of risks.
87
 These risks include 
general anesthesia, infection, pain, discomfort, and the risks that are associated with blood 
transfusion.
88
 Donating an organ involves even more physical risk than a bone marrow 
donation.
89
 To request a savior sibling to donate their organs unfairly subjects themselves to 
physical pain and weakness that reaps no benefits for the savior child.
90
 
When it comes to the moral considerations, Knoppers separates them into two main 
points of view that are widely debated. The first view is that the embryo is a new human life 
entitled to full moral status from the time of fertilization because from that time it holds the 
potential to develop into a complete human being.
91
 The other view is that the embryo has some 
moral status from fertilization, but to a lesser extent than a born human being, and gradually 
acquires “full” moral status during development.92 This paper is focused on the ethical 
considerations rather than the moral aspects of savior siblings. 
 
iv. Tests 
There is a sub-argument regarding the welfare of a child called the net-benefit argument. 
In an article written by Sheldon and Wilkinson in 2001, they make it clear that they believe that 
an embryo should be exposed to the risks of PGD only if it (or the person it becomes) is likely to 
derive enough benefit to outweigh those risks.
93
 Basically, the potential child is thought to be 
                                                 
87 See Fasbender, supra note 48, at 21. 
88 Id. 
89 Id. 
90 Amy T. Y. Lai, To Be or Not To Be My Sister's Keeper?, 32 J. LEGAL MED. 261 (2011). 
91 See Knoppers, supra note 51. 
92 Id. 
93 See Fasbender, supra note 48. 
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like an existing patient. Since the embryo is viewed as a potential child, proponents of this 
reasoning afford the embryo the same moral status as that of a born child.
94
 
In an article written by S.M. Wolf, she explains that PGD to avoid serious and early-onset 
illness in a child-to-be is widely accepted.
95
 This type of screening of an embryo reduces the 
chances of parents having a child that is affected by a genetic or chromosomal disorder in which 
the parents are possibly faced with the decision of aborting the child or living with the challenges 
of raising an ill or disable child.
96
 When PGD is used in this manner, it is being done in the best 
interest of the embryo or the person that that embryo will become.
97
 However, controversy arises 
when PGD is used solely for tissue typing because the only one who benefits from that type of 
screening is the existing sick child.
98
 
Tissue typing “is a group of procedures that determines the type of histocompatibility 
antigens on a person’s cells or tissues.”99 The procedure of tissue typing is generally used prior 
to transplantations in order “to ensure as close a match as possible between the donor and the 
recipient.”100 If the antigens are not perfectly matched, there is a change that the donated tissue 
will be rejected by the recipient.
101
 
 
 v. Ethical Conclusion 
The idea of a savior sibling will forever be debatable. Among the three main arguments 
which include children as commodities, designer babies, and the welfare of the child, only one 
                                                 
94 Id. 
95 S.M. Wolf, Using Preimplantation Genetic Diagnosis to Create a Stem Cell Donor: Issues, Guidelines, and 
Limits, J. OF LAW MED. AND ETHICS 327-339, (2003). 
96 Id. 
97 See Devolder, supra note 57. 
98 Id. 
99 Farlex, Inc., Medical Dictionary, 2013, available at http://medical-dictionary.thefreedictionary.com/tissue+typing, 
(last visited May 9, 2013). 
100 Id. 
101 Id. 
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argument holds much merit. That argument is the welfare of the child. When it comes to children 
as commodities, there is more convincing literature that turns on the fact that life is better than 
non-existence. Basically every argument against savior siblings gets fumbled when it comes to 
the fact that life is better than non-existence. 
Children as commodities fails as an argument not only because of the point discussed 
above, but because every day couples are having children for many other reasons besides “the 
right ones”. There is really no way to regulate or determine why a child is born into this world. 
 The argument that the allowance of savior siblings will lead down a slippery slope and 
eventually lead to designer babies is a weak argument as well. It is extremely difficult to 
categorize together having a child to save another child with having a child with blue eyes 
instead of brown. The two arguments should not be places within the same category as they are 
completely different in nature and scope. 
 However, the slippery close argument is a strong argument in the United States where 
there is no regulation at all of the use of PGD. Any type of technology that is this advanced and 
this life-impacting should be regulated or it could get out of hand. In countries where regulations 
are clearly set in place, there are no worries of a slippery slope because it would be illegal to 
have a child born with exact specifications like hair color, eye color, and skin type. This 
argument makes it more imperative for the United States to step up and follow the examples of 
other countries before it is too late and our technology get abused. The laws of the U.S. and other 
countries to regulate PGD will be discussed thoroughly in the next section. 
 The argument with the most merit is the argument about the welfare of the child. There’s 
no possible way to know exactly what the outcome will be of the already existing child if a 
15 
 
savior sibling is created to save that child. However, what parent wouldn’t give their child every 
ounce of a chance of survival? 
 
IV. The Laws 
 
While the ethical debate will be forever on-going, the demand for PGD for stem cell 
transplantation from similarly-situated families to the Nash’s soared as news spread about their 
experience.
102
 Moreover, such demand is likely to continue to grow exponentially given the 
recent success and the variety of diseases for which it can be used. 
103
 Therefore, it is quite 
perplexing that the United States, being as far-reaching in medical, moral, and ethical 
implications, has allowed PGD to go forth largely unregulated.
104
  
Other countries, such as Australia and the United Kingdom, so closely oversee the use of 
both IVF and PGD and other countries such as Austria, Germany, Ireland, and Switzerland have 
outlawed PGD altogether.
105
 There are four different ways that PGD can be regulated. In the next 
sections, this paper will analyze those ways and those countries that regulate IVF and PGD. 
 
i. Statutory Ban on PGD 
 
A statutory ban on PGD simply means that PGD is not allowed to be performed. 
Countries among this category include Germany, Switzerland, Ireland, Western Australia, and 
                                                 
102 See Lai, supra note 90. 
103 Id. 
104 Id. 
105 Id. 
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Austria.
106
 These types of bans are put in place for a number of ethical, moral and social 
reasons.
107
 For example, Germany currently does not allow PGD based on the premise that the 
embryo has the right to life and performing PGD is unacceptable because it will likely result in 
the destruction of embryos that carry disease-linked genes.
108
 
This type of ban has led to what is known as “medical tourism.”109 This term implies that 
a couple who lives where there are restrictive laws on PGD will travel to different areas of the 
world to obtain treatment where it can be legally done.
110
 There are several problems with 
medical tourism.
111
 First, patients tend to lack the proper follow-up care, and, therefore, 
complications of the surgery or the side effects of certain drugs are not taken care of.
112
 Patients 
may also not tolerate travel well, or may be subject to catching diseases in the countries they 
travel to for medical care.
113
 In a survey carried out by the British Association of Plastic, 
Reconstructive and Aesthetic surgery, thirty-seven percent of 203 people had complications 
arising out of overseas surgery.
114
 
 
ii. Statutory Mandatory Licensing 
This type of regulation occurs when a section of the government regulated PGD by 
requiring a clinic to obtain a license before they can perform PGD.
115
 Countries that follow this 
                                                 
106 Id. 
107 Id. 
108 Savior Siblings, Is PGD Being Regulated?, 2009, available at 
http://ourethicaljourney09.blogspot.com/2009_06_01_archive.html, (last visited May 2, 2013). 
109 Id. 
110 Id. 
111 Lamk Al Lamki, Medical Tourism, Beneficence or Maleficence?, 11 SULTAN QABOOS UNIV. MED. J. 444-447, 
(2011). 
112 Id. 
113 Id. 
114 Id. 
115 See Savior Siblings, supra Note 108. 
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structure include the UK and France.
116
 In the UK, PGD is regulated by the Human Fertilization 
and Embryology Act (HFEA).
117
 This Act was enacted in 1990.
118
 The UK allowed for PGD to 
be performed to test for severe genetic diseases and tissue type matching for savior siblings 
under strict criteria. However, the UK does not allow gender selection.
119
 Under the UK’s 
regulations, a clinic must apply for a new license for every new genetic disease they would like 
for test for in an embryo. What this form of regulation does is create clear and legally 
enforceable rules.
120
 However, is it fair to leave the decision of unacceptable vs. acceptable uses 
of PGD in the hands of others?
121
 
 The main focus of the HFEA is to monitor and license any clinics that perform 
IVF, donor insemination, or clinics that store gametes and embryos.
122
 The HFEA is also in 
charge of regulation embryo research, while also creating a Code of Practice with guidelines for 
the clinics performing these types of treatments.
123
 The HFEA also provides advice to parents, 
patients, and physicians and keeps a register of all children born from these treatments.
124
 
 
iii. US position 
No law or regulatory process has been enacted in the U.S. to limit the use of PGD to cure 
disease. The United States is currently a non-regulatory country.
125
 Because of this, the uses of 
                                                 
116 Id. 
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PGD are left to the discretion of its providers.
126
 What this sort of regulation does is avoid 
governmental interference in personal choices and the continuation of innovative scientific 
progress without regulation.
127
 However, there are many flaws in a system like this. Not having 
any type of regulation gives the authority to PGD clinics to make their own decision on moral 
and ethical issues concerning PGD.
128
 Each clinic will make their own separate policies and 
services.
129
 With non-regulation, one clinic can allow using PGD to select the gender of the 
baby, while others will use it for screening for severe genetic conditions.
130
 Non-regulation gives 
too much power to the PGD clinics to make their own moral and ethical decisions.
131
 More than 
two-thirds of the approximately fifty fertility clinics worldwide offering PGD are found in the 
United States because of the lack of regulation.
132
 
 
 iv. Self-Regulation by Professional Organizations 
 
Under this type of self-regulation, PGD is regulated through guidelines issued by 
professional organizations.
133
 If a clinic fails to abide by these guidelines, it can result in the 
withdrawal of a clinic’s membership in the organization.134  
An example of a country that regulated PGD through professional organizations is 
Japan.
135
 Japan has two professional organization designed for this purpose.
136
 Japan’s guidelines 
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require that PGD only be apply to “serious hereditary disorders,” or, in the case of sex selection, 
to “serious sex-linked recessive hereditary disorders.”137 PGD clinics must get approval from the 
organizations before they can perform PGD.
138
 
In the U.S., PGD service suppliers only need to follow the ethical guidelines of two 
committees: the American Society for Reproductive Medicine and the American Medical 
Association.
139
 The American Society for Reproductive Medicine addresses the general use of 
the PGD, while the American Medical Association states that the use of PGD is permissible “to 
prevent, cure, or treat genetic disease” and not for the “selection on the basis of non-disease 
related characteristics or traits.”140 This is considered self-regulation, rather than regulation on a 
state or federal level. 
 Also in the U.S. every use of Assistive Reproductive Technology (ART) must be 
reported.
141
 In 1992, the Fertility Clinic Success Rate and Certificate Act was passed by 
Congress which required each ART program to complete an annual report.
142
 This annual report 
must include the success and failure rates of ART at each clinic.
143
 
 
V. Cases in the US 
 
Since the U.S. is in the non-regulated category, there have not been cases that deal 
directly with the use of PGD for use to cure a disease, but there have been several cases that have 
utilized the ideals discussed above. Two of those cases are Strunk v. Strunk and Hart v. Brown. 
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It is important to discuss these cases in regards to the U.S. because, since the U.S. is non-
regulated, it is the only type of reference available in regards to this type of procedure. 
In Strunk v. Strunk (1969), Arthur Strunk and Ava Strunk were the parents of two 
sons.
144
 One of those sons was Tommy Strunk who at the time was twenty-eight years old, 
married, an employee of the Penn State Railroad, and a part-time student at the University of 
Cincinnati.
145
 Tommy was suffering from chronic glomerulus nephritis, a fatal kidney disease, 
and was being kept alive by frequent treatment on an artificial kidney.
146
 However, that 
procedure could not be continued much longer.
147
 Jerry Strunk was twenty-seven years old at the 
time this was occurring.
148
 He was deemed incompetent, and had been committed to the 
Frankfort State Hospital and School, an institution maintained for the feebleminded.
149
 His I.Q. 
was approximately 35, which puts him in the mental age category of a healthy six year old.
150
 
It was determined that Tommy, in order to survive, would have to have a kidney 
transplant.
151
 The entire family was tested and found to be incompatible except Jerry.
152
 Ava 
Strunk petitioned the county court for authority to proceed with the operation.
153
 The court found 
that the operation was necessary, that under the peculiar circumstances of the case it would not 
only be beneficial to Tommy, but also beneficial to Jerry because Jerry was greatly dependant 
upon Tommy, both emotionally and psychologically.
154
 The court continued to explain that 
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Jerry’s well-being would be jeopardized more severely by the loss of his brother than by the 
removal of his kidney.
155
 This case is an example of the net-benefit test. 
In Hart v. Brown (1972), Peter Hart and Eleanor Hart were the parents and natural 
guardians of Kathleen and Margaret Hart, identical seven year old twins.
156
 Kathleen Hart was a 
patient in the Yale-New Haven Hospital suffering from hemolytic uremic syndrome and awaiting 
a kidney transplant.
157
 This disease is a disorder of the kidneys which clogs within the small 
blood vessels.
158
 The physicians in this case were the defendants and had in the past performed 
successful kidney transplants and were of the opinion that a successful transplantation operating 
could be performed on the minors, Kathleen as the donee and Margaret as the donor.
159
 
The parents of the children have given their permission for the operation of the kidney, 
but the physicians were unwilling to perform the operation and the hospital refused to use their 
facilities unless the court declared that the parents had the right to give their consent to the 
operation upon the minor twins.
160
 The operating surgeon testified that the surgical risk is no 
more than the risk of the anesthesia, the procedure would last about two and one-half hours, and 
that there would be some minor postoperative pain but no more than in any other surgical 
procedure.
161
 Assuming an uneventful recovery, the child would be able to engage in all of the 
normal life activities of an active young girl.
162
 The only real risk would be the trauma to the one 
remaining kidney in the donor.
163
 The legal problems discussed in this case were the balancing of 
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the rights of the natural parents and the rights of minor children, more focused, the rights of the 
donor child.
164
 
The court stated that it appeared that the natural parents would be able to substitute their 
consent for that of their minor children after a close, independent and objective investigation of 
their motivation and reasoning.
165
 This had been accomplished in this matter by the participating 
of a clergyman, the defendant physicians, an attorney guardian ad litem for the donor, the 
guardian ad litem for the donee, and indeed, through the court itself.
166
 
The court cited to Strunk v. Strunk pointing out that the difference between the two cases 
was subtle.
167
 The donor in the instant case was almost eight years old. In the Strunk case, the 
donor was an adult with the mental capacity of a six year old.
168
 The risks to the donee in the 
Strunk care were more than what as presented in the present case.
169
 The court concluded that 
natural parents of a minor should have the right to give their consent for the kidney transplant.
170
 
These cases, and cases like them, show the court’s attitude behind the idea of a savior 
sibling in the United States. 
 
VI. Opinions and Suggestions 
 a. The Best and Worst Regulatory Choices 
 The United States’ example of non-regulation is not one which should be followed. As 
stated above, this type of regulatory process leaves the process of implementing PGD to the 
discretion of its providers. Because of this, clinics will make their own separate policies and 
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services which negates the idea of having a uniform system of the law. Non-regulation gives too 
much power to the PGD clinics to make life-impacting moral and ethical decisions. If PGD is not 
regulated, it will be taken advantage of and eventually led down the slippery slope path that is 
imperative to avoid. 
The idea of using a non-parental guardian, as in the cases discussed above, and 
advocating on a child’s behalf, stems from having a non-regulatory system set in place. Cases 
like Hart v. Brown arise because the physicians choose to not perform operations without court’s 
approval. This is obviously not always the case and since PGD is not regulated, many cases go 
unheard. 
 The idea of a statutory ban on PGD is on the other side of the spectrum. As mentioned 
above, these countries disallow any form of the use of PGD whether it is to choose the sex of a 
child or to save another child’s life. The issue with this type of ban is fairly obvious. If one 
country bans the use of PGD and a child is sick, the family will temporarily take a “medical 
tour” to a country where it is legal and get the medical help they need. It is not right to impose a 
single moral or ethical perspective on others when there are so many different views and so 
many different type of cases and levels of importance. 
 Statutory mandatory licensing is a step in the right direction, especially when it comes to 
the UK. The UK’s use of the Human Fertilization and Embryology Act should be an example for 
all countries to learn from. Each individual clinic is under the same set of guidelines and rules 
and must apply for a license for each new disease that they would like to test an embryo for. This 
helps the HFEA keep track of developments and set clear rules. 
 Regulation by professional organizations is by far the best choice of all four choices. This 
is basically what is known as a “case-by-case” basis, which is exactly how PGD should be 
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handled. The UK, for example, although structured so tightly, does not allow for the use of PGD 
for sex selection. At first glance, this might seem like the right guideline to have so that couples 
are not abusing the power of being able to choose the sex of their child. However, some serious 
sex-linked hereditary disorders have a chances of occurring as high as eighty percent in males, 
but only ten percent in females. In these types of cases, the technology we have in the world 
today should be used to potentially avoid bringing a child into the world that has only a twenty 
percent chance at being healthy. 
 
VII. Conclusion 
 
 The use of IVF and PGD should be regulated on a case-by-case basis in order to give 
each child and each situation its rightful time to be heard and evaluated. If our modern 
technology can be used to save lives, there is no reason for that type of knowledge to be 
unavailable. However, a lack of regulation can lead to obvious misuse of this type of technology, 
and, therefore regulation is imperative. 
